A Structural Voyage Toward the Landscape of Humoral and Cellular Immune Escapes of SARS‐CoV‐2.

The genome‐based surveillance of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) in the past nearly 5 years since its emergence has refreshed our understanding of virus evolution, especially on convergent co‐evolution with the host. SARS‐CoV‐2 evolution has been characterized by the emergence of sets of mutations that affect the functional properties of the virus by altering its infectivity, virulence, transmissibility, and interactions with host immunity. This poses a huge challenge to global prevention and control measures based on drug treatment and vaccine application. As one of the key evasion strategies in response to the immune profile of the human population, there are overwhelming amounts of evidence for the reduced antibody neutralization of SARS‐CoV‐2 variants. Additionally, data also suggest that the levels of CD4+ and CD8+ T‐cell responses against variants or sub‐variants decrease in the populations, although non‐negligible cross‐T‐cell responses are maintained. Herein, from the perspectives of structural immunology, we outline the characteristics and mechanisms of the T cell and antibody responses to SARS‐CoV and its variants/sub‐variants. The molecular bases for the impact of the immune escaping variants on the interaction of the epitopes with the key receptors in adaptive immunity, that is, major histocompatibility complex (MHC), T‐cell receptor (TCR), and antibody are summarized and discussed, the knowledge of which will widen our understanding of this pandemic‐threatening virus and assist the preparedness for Pathogen X in the future. [ABSTRACT FROM AUTHOR]